The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1
Open accessAbstract
Dysregulation of microRNAs is a common feature in human cancers, including breast cancer (BC). Here we describe the epigenetic regulation of miR-148a and miR-152 and their impact on BC cells. Due to the hypermethylation of CpG island, the expression levels of both miR-148a and miR-152 (miR-148a/152) are decreased in BC tissues and cells. DNMT1, the DNA methyltransferase 1 for the maintenance methylation, is aberrantly up-regulated in BC and its overexpression is responsible for hypermethylation of miR-148a and miR-152 promoters. Intriguingly, we found that DNMT1 expression, which is one of the targets of miR-148a/152, is inversely correlated with the expression levels of miR-148a/152 in BC tissues. Those results lead us to propose a negative feedback regulatory loop between miR-148a/152 and DNMT1 in BC. More importantly, we demonstrate that IGF-IR and IRS1, often overexpressed in BC, are two novel targets of miR-148a/152. Overexpression of miR-148a or miR-152 significantly inhibits BC cell proliferation, colony formation, and tumor angiogenesis via targeting IGF-IR and IRS1 and suppressing their downstream AKT and MAPK/ERK signaling pathways. Our results suggest a novel miR-148a/152-DNMT1 regulatory circuit and reveal that miR-148a and miR-152 act as tumor suppressors by targeting IGF-IR and IRS1, and that restoration of miR-148a/152 expression may provide a strategy for therapeutic application to treat BC patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
MicroRNA Gene Expression Deregulation in Human Breast Cancer
Iorio, M. V., Ferracin, M., Liu, C.-G., Veronese, A., Spizzo, R., Sabbioni, S., Magri, E., Pedriali, M., Fabbri, M., Campiglio, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1783 · Cited by 4,053
Epigenetics in human disease and prospects for epigenetic therapy
Egger, G., Liang, G., Aparicio, A., & Jones, P. A. (2004) · Nature · doi:10.1038/nature02625 · Cited by 3,232
A MicroRNA Signature Associated with Prognosis and Progression in Chronic Lymphocytic Leukemia
Calin, G. A., Ferracin, M., Cimmino, A., Di Leva, G., Shimizu, M., Wojcik, S. E., Iorio, M. V., Visone, R., Sever, N. I., Fabbri, M., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050995 · Cited by 2,403
Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery
Hennessy, B. T., Smith, D. L., Ram, P. T., Lu, Y., & Mills, G. B. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1902 · Cited by 2,185
The DNA methyltransferases of mammals
Bestor, T. H. (2000) · Human Molecular Genetics · doi:10.1093/hmg/9.16.2395 · Cited by 2,041
Berns, K., Horlings, H. M., Hennessy, B. T., Madiredjo, M., Hijmans, E. M., Beelen, K., Linn, S. C., Gonzalez-Angulo, A. M., Stemke-Hale, K., Hauptmann, M., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.08.030 · Cited by 1,627
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
Epigenetics: Regulation Through Repression
Wolffe, A. P., & Matzke, M. A. (1999) · Science · doi:10.1126/science.286.5439.481 · Cited by 1,239
Oxygen Sensing, Homeostasis, and Disease
Semenza, G. L. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011165 · Cited by 993
Robertson, K. D., Uzvolgyi, E., Liang, G., Talmadge, C., Sumegi, J., Gonzales, F. A., & Jones, P. A. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.11.2291 · Cited by 853
DNA hypomethylation and human diseases
Wilson, A. S., Power, B. E., & Molloy, P. L. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.08.007 · Cited by 804
Brooks, P. C., Silletti, S., von Schalscha, T. L., Friedlander, M., & Cheresh, D. A. (1998) · Cell · doi:10.1016/s0092-8674(00)80931-9 · Cited by 623
Exploration of Tumor-Suppressive MicroRNAs Silenced by DNA Hypermethylation in Oral Cancer
Kozaki, K.-I., Imoto, I., Mogi, S., Omura, K., & Inazawa, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5194 · Cited by 613
Toyota, M., Suzuki, H., Sasaki, Y., Maruyama, R., Imai, K., Shinomura, Y., & Tokino, T. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0325 · Cited by 600
Structural biology of insulin and IGF1 receptors: implications for drug design
De Meyts, P., & Whittaker, J. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd917 · Cited by 582
Pan, W., Zhu, S., Yuan, M., Cui, H., Wang, L., Luo, X., Li, J., Zhou, H., Tang, Y., & Shen, N. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0904060 · Cited by 561
Jiang, B.-H., Zheng, J. Z., Aoki, M., & Vogt, P. K. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040560897 · Cited by 528
Self-citationXia, C., Meng, Q., Liu, L.-Z., Rojanasakul, Y., Wang, X.-R., & Jiang, B.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0783 · Cited by 507
Self-citationEpigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer
Lehmann, U., Hasemeier, B., Christgen, M., Müller, M., Römermann, D., Länger, F., & Kreipe, H. (2008) · The Journal of Pathology · doi:10.1002/path.2251 · Cited by 460
Mizuno, S.-I., Chijiwa, T., Okamura, T., Akashi, K., Fukumaki, Y., Niho, Y., & Sasaki, H. (2001) · Blood · doi:10.1182/blood.v97.5.1172 · Cited by 438
Huang, J., Wang, Y., Guo, Y., & Sun, S. (2010) · Hepatology · doi:10.1002/hep.23660 · Cited by 342
Epigenetic Silencing of miR-137 Is an Early Event in Colorectal Carcinogenesis
Balaguer, F., Link, A., Lozano, J. J., Cuatrecasas, M., Nagasaka, T., Boland, C. R., & Goel, A. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0622 · Cited by 293
MiR-145 directly targets p70S6K1 in cancer cells to inhibit tumor growth and angiogenesis
Xu, Q., Liu, L.-Z., Qian, X., Chen, Q., Jiang, Y., Li, D., Lai, L., & Jiang, B.-H. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr730 · Cited by 284
Self-citationKarpf, A. R., & Matsui, S.-I. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1961 · Cited by 276
Liu, X., Zhan, Z., Xu, L., Ma, F., Li, D., Guo, Z., Li, N., & Cao, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001573 · Cited by 269
Zheng, B., Liang, L., Wang, C., Huang, S., Cao, X., Zha, R., Liu, L., Jia, D., Tian, Q., Wu, J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1714 · Cited by 269
Self-citationSUMOylation Mediates the Nuclear Translocation and Signaling of the IGF-1 Receptor
Sehat, B., Tofigh, A., Lin, Y., Trocmé, E., Liljedahl, U., Lagergren, J., & Larsson, O. (2010) · Science Signaling · doi:10.1126/scisignal.2000628 · Cited by 244
Epigenetic silencing and deletion of the BRCA1gene in sporadic breast cancer
Birgisdottir, V., Stefansson, O. A., Bodvarsdottir, S. K., Hilmarsdottir, H., Jonasson, J. G., & Eyfjord, J. E. (2006) · Breast Cancer Research · doi:10.1186/bcr1522 · Cited by 238
DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines
Roll, J. D., Rivenbark, A. G., Jones, W. D., & Coleman, W. B. (2008) · Molecular Cancer · doi:10.1186/1476-4598-7-15 · Cited by 224
Hildebrandt, M. A. T., Gu, J., Lin, J., Ye, Y., Tan, W., Tamboli, P., Wood, C. G., & Wu, X. (2010) · Oncogene · doi:10.1038/onc.2010.305 · Cited by 205
Altered Expression of MiR-148a and MiR-152 in Gastrointestinal Cancers and Its Clinical Significance
Chen, Y., Song, Y., Wang, Z., Yue, Z., Xu, H., Xing, C., & Liu, Z. (2010) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-010-1202-2 · Cited by 201
Soares, J., Pinto, A. E., Cunha, C. V., Andr�, S., Bar�o, I., Sousa, J. M., & Cravo, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990101)85:1<112::aid-cncr16>3.0.co;2-t · Cited by 187
Dearth, R. K., Cui, X., Kim, H.-J., Kuiatse, I., Lawrence, N. A., Zhang, X., Divisova, J., Britton, O. L., Mohsin, S., Allred, D. C., et al. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00260-06 · Cited by 165
miR-107 promotes tumor progression by targeting the let-7 microRNA in mice and humans
Chen, P., Su, J.-L., Cha, S.-T., Tarn, W., Wang, M.-Y., Hsu, H.-C., Lin, M., Chu, C., Hua, K., Chen, C., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45390 · Cited by 155
Hanoun, N., Delpu, Y., Suriawinata, A. A., Bournet, B., Bureau, C., Sèlves, J., Tsongalis, G. J., Dufresne, M., Buscail, L., Cordelier, P., et al. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.144709 · Cited by 149
Adenomatous polyposis coli (APC) gene promoter hypermethylation in primary breast cancers
Jin, Z., Tamura, G., Tsuchiya, T., Sakata, K., Kashiwaba, M., Osakabe, M., & Motoyama, T. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2001.1853 · Cited by 147
Chang, Q., Li, Y., White, M. F., Fletcher, J. A., & Xiao, S. (2002) · PubMed · Cited by 121
DNA Methylation in Ovarian Cancer
Ahluwalia, A., Hurteau, J. A., Bigsby, R. M., & Nephew, K. P. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6284 · Cited by 118
Mirza, S., Sharma, G., Prasad, C. P., Parshad, R., Srivastava, A., Gupta, S. D., & Ralhan, R. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.05.012 · Cited by 113
Stumpel, D. J. P. M., Schotte, D., Turenhout, E. A. M., Schneider, P., Seslija, L., de Menezes, R. X., Márquez, V. E., Pieters, R., den Boer, M. L., & Stam, R. W. (2010) · Leukemia · doi:10.1038/leu.2010.282 · Cited by 108
DNA hypomethylation in breast cancer: An independent parameter of tumor progression?
Bernardino-Sgherri, J., Roux, C., Almeida, A., Vogt, N., Gibaud, A., Gerbault‐Seureau, M., Magdelénat, H., Bourgeois, C. A., Malfoy, B., & Dutrillaux, B. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00385-8 · Cited by 81
Promoter methylation and the detection of breast cancer
Brooks, J. D., Cairns, P., & Zeleniuch‐Jacquotte, A. (2009) · Cancer Causes & Control · doi:10.1007/s10552-009-9415-y · Cited by 79
Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer
Tamimi, R. M., Colditz, G. A., Wang, Y., Collins, L. C., Hu, R., ROSNER, B. A., Irie, H. Y., Connolly, J. L., & Schnitt, S. J. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1313-1 · Cited by 73
Rincon, S. V. D., Guo, Q., Morelli, C., Shiu, H. Y., Surmacz, E., & Miller, W. H. (2004) · Oncogene · doi:10.1038/sj.onc.1208104 · Cited by 66
PI3 Kinase Activation and Response to Trastuzumab Therapy: What's neu with Herceptin Resistance?
Park, B. H., & Davidson, N. E. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.004 · Cited by 47
DNA Methylation Profiles of Female Steroid Hormone-Driven Human Malignancies
Campan, M., Weisenberger, D. J., & Laird, P. W. (2006) · Springer eBooks · doi:10.1007/3-540-31181-5_8 · Cited by 37
Growth inhibition by microRNAs that target the insulin receptor substrate-1
Rocca, G. L., Shi, B., Badin, M., Angelis, T. D., Sepp‐Lorenzino, L., & Baserga, R. (2009) · Cell Cycle · doi:10.4161/cc.8.14.9026 · Cited by 20
Epigenetic Biomarkers and Breast Cancer: Cause for Optimism
Visvanathan, K., Sukumar, S. V., & Davidson, N. E. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2001 · Cited by 10
Cited by
The pro-metastasis effect of circANKS1B in breast cancer
Zeng, K., He, B., Yang, B. B., Xu, T., Chen, X., Xu, M., Liu, X., Sun, H., Pan, Y., & Wang, S. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0914-x · Cited by 319
Interplay between the miRNome and the epigenetic machinery: Implications in health and disease
Poddar, S., Kesharwani, D., & Datta, M. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.25819 · Cited by 57
Analysis of miRNA expression profiles in breast cancer using biclustering
Fiannaca, A., La Rosa, M., La Paglia, L., Rizzo, R., & Urso, A. (2015) · BMC Bioinformatics · doi:10.1186/1471-2105-16-s4-s7 · Cited by 45
Breast Cancer and the Other Non-Coding RNAs
Dvorská, D., Braný, D., Ňachajová, M., Halašová, E., & Danková, Z. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063280 · Cited by 38
Metadata
- Authors
- Xu, Q., Jiang, Y., Yin, Y., Li, Q., He, J., Jing, Y., Qi, Y.-T., Xu, Q., Li, W., Lu, B., Peiper, S. S., Jiang, B.-H., & Liu, L.-Z.
- Venue
- Journal of Molecular Cell Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2012-08-29
- Volume
- 5
- Issue
- 1
- Pages
- 3-13
- ISSN
- 1674-2788 (ISSN-L)
- 1759-4685
- OpenAlex
- W2107684325
- Cited by
- 285
- References
- 50
- FWCI
- 7.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.